
  
    
      
        Background_NNP
        Obesity_NNP is_VBZ rapidly_RB becoming_VBG one_CD of_IN the_DT most_RBS important_JJ
        medical_JJ and_CC public_JJ health_NN problems_NNS of_IN our_PRP$ time_NN ._. Obesity_NNP is_VBZ
        associated_VBN with_IN a_DT high_JJ rate_NN of_IN morbidity_NN and_CC early_JJ
        mortality_NN if_IN left_VBD untreated_JJ [_NN 1_CD 2_CD 3_CD 4_CD ]_NN ._. Studies_NNPS indicate_VBP
        that_IN the_DT presence_NN of_IN obesity_NN increases_VBZ the_DT risk_NN for_IN
        developing_VBG cardiovascular_JJ diseases_NNS and_CC diabetes_NN [_NN 5_CD 6_CD 7_CD 8_CD ]_NN
        ._. Its_PRP$ role_NN as_IN a_DT health_NN hazard_NN in_IN adults_NNS has_VBZ been_VBN well_RB
        recognized_VBN for_IN some_DT time_NN [_NN 1_CD 2_CD 3_CD 4_CD 5_CD 6_CD 7_CD 8_CD 9_CD 10_CD 11_CD 12_CD 13_CD ]_NN
        but_CC little_JJ attention_NN has_VBZ been_VBN paid_VBN to_TO childhood_NN and_CC
        adolescent_JJ obesity_NN [_NN 14_CD 15_CD 16_CD 17_CD ]_NN ._.
        The_DT prevalence_NN of_IN obesity_NN among_IN US_NNP children_NNS is_VBZ
        approximately_RB of_IN 22_CD -_: 30_CD %_NN and_CC has_VBZ increased_VBN at_IN an_DT
        accelerating_VBG rate_NN in_IN the_DT past_JJ several_JJ years_NNS [_NN 18_CD 19_CD 20_CD ]_NN ;_:
        the_DT prevalence_NN of_IN obesity_NN is_VBZ >_NN 30_CD %_NN in_IN some_DT pediatric_JJ
        populations_NNS [_NN 20_CD 21_CD ]_NN ._. Obesity_NNP in_IN childhood_NN is_VBZ associated_VBN
        with_IN obesity_NN in_IN adulthood_NN [_NN 22_CD 23_CD 24_CD 25_CD ]_NN ,_, and_CC is_VBZ a_DT
        predictor_NN of_IN all_DT causes_NNS of_IN obesity-associated_JJ mortality_NN
        during_IN adulthood_NN ,_, particularly_RB mortality_NN from_IN
        cardiovascular_JJ diseases_NNS ,_, which_WDT are_VBP independent_JJ of_IN adult_NN
        weight_NN [_NN 24_CD 25_CD ]_NN ._. Epidemiologic_NNP evidence_NN supports_VBZ the_DT
        theory_NN that_IN the_DT relation_NN between_IN obesity_NN and_CC disease_NN risk_NN
        begins_VBZ early_RB in_IN life_NN ._. For_IN instance_NN ,_, adolescents_NNS who_WP died_VBD in_IN
        accidents_NNS had_VBD fatty_NN streaks_NNS in_IN the_DT coronary_JJ arteries_NNS and_CC
        aorta_NN that_WDT were_VBD found_VBN at_IN ,_, autopsy_NN ,_, and_CC were_VBD associated_VBN with_IN
        blood_NN lipid_NN profile_NN ,_, blood_NN pressure_NN ,_, and_CC obesity_NN status_NN
        obtained_VBN at_IN one_CD or_CC more_JJR points_NNS antemortem_NN [_NN 26_CD 27_CD ]_NN ._.
        Moreover_RB ,_, a_DT recent_JJ longitudinal_NN study_NN indicated_VBD that_IN the_DT
        occurrence_NN of_IN overweight_NN ,_, hypertension_NN ,_, and_CC dyslipidemia_NN in_IN
        young_JJ adults_NNS (_( aged_VBN 19_CD -_: 32_CD y_NN )_) was_VBD associated_VBN with_IN these_DT same_JJ
        risk_NN factors_NNS in_IN childhood_NN ._. Data_NNS from_IN the_DT Children_NNP 's_POS
        Hospital_NNP Medical_NNP Center_NNP in_IN Cincinnati_NNP have_VBP shown_VBN that_IN the_DT
        incidence_NN of_IN type_NN 2_CD diabetes_NN among_IN adolescents_NNS increased_VBD
        10_CD -_: fold_VB from_IN 1982_CD to_TO 1994_CD ,_, and_CC virtually_RB all_DT diagnosed_VBN
        cases_NNS of_IN type_NN 2_CD diabetes_NN occurred_VBD in_IN obese_NN individuals_NNS [_NN 28_CD
        ]_NN ._. These_DT observations_NNS are_VBP likely_JJ to_TO reflect_VB national_JJ
        trends_NNS and_CC certainly_RB deserve_VBP both_DT confirmation_NN ,_, and_CC a_DT
        sharper_JJR focus_NN ._.
        To_TO test_VB the_DT hypothesis_NNS that_IN being_VBG an_DT overweight_NN or_CC obese_NN
        adolescent_NN is_VBZ associated_VBN with_IN early_JJ appearance_NN of_IN glucose_NN
        and_CC lipid_NN profile_NN abnormalities_NNS ,_, we_PRP performed_VBD a_DT
        case-control_JJ study_NN quantifying_VBG the_DT odds_NNS ratio_NN of_IN overweight_NN
        and_CC obesity_NN on_IN these_DT abnormalities_NNS through_IN different_JJ
        Tanner_NNP 's_POS stages_NNS ._. The_DT association_NN between_IN glucose_NN and_CC lipid_NN
        profiles_NNS and_CC the_DT distribution_NN of_IN adipose_NN tissue_NN was_VBD also_RB
        tested_VBN in_IN this_DT study_NN ._. The_DT objective_NN of_IN the_DT second_JJ study_NN was_VBD
        to_TO determine_VB ._. from_IN a_DT retrospective-prospective_JJ longitudinal_NN
        study_NN of_IN overweight_NN and_CC obese_NN male_JJ and_CC females_NNS having_VBG
        abnormal_JJ glucose_NN and_CC /_NN or_CC lipid_NN profiles_NNS at_IN which_WDT age_VBP obesity_NN
        in_IN adolescence_NN can_MD be_VB predictive_JJ of_IN adult_NN obesity_NN and_CC its_PRP$
        obesity-associated_JJ cardiovascular_JJ risk_NN factors_NNS ._.
      
      
        Methods_NNP
        
          Study_NNP 1_CD
          The_DT first_JJ investigation_NN was_VBD designed_VBN as_IN a_DT case-control_JJ
          study_NN and_CC was_VBD performed_VBN in_IN hospitals_NNS associated_VBN with_IN
          Montreal_NNP and_CC McGill_NNP Universities_NNS ._. Many_JJ of_IN the_DT subjects_NNS
          were_VBD also_RB directly_RB recruited_VBN from_IN nursery_NN schools_NNS ._. This_DT
          study_NN was_VBD conducted_VBN to_TO determine_VB the_DT relationship_NN between_IN
          various_JJ indicators_NNS of_IN adiposity_NN and_CC risk_NN factors_NNS for_IN
          cardiovascular_JJ diseases_NNS in_IN Caucasian_NNP normal_JJ ,_, overweight_NN ,_,
          and_CC obese_NN male_JJ and_CC female_JJ adolescents_NNS ._. The_DT prevalence_NN and_CC
          odds_NNS ratio_NN of_IN being_VBG overweight_NN or_CC obese_NN on_IN glucose_NN and_CC
          lipid_NN profiles_NNS was_VBD also_RB determined_VBN ._. Each_DT Tanner_NNP stage_NN is_VBZ
          associated_VBN with_IN important_JJ changes_NNS in_IN genital_JJ development_NN
          and_CC sexual_JJ hormone_NN profiles_NNS ,_, which_WDT could_MD have_VB an_DT impact_NN
          on_IN adipose_NN tissue_NN distribution_NN and_CC glucose_NN and_CC lipid_NN
          profiles_NNS ._. Informed_NNP written_VBN consent_NN was_VBD obtained_VBN from_IN the_DT
          parents_NNS and_CC /_NN or_CC of_IN all_DT participating_VBG subjects_NNS ._. The_DT
          participants_NNS were_VBD recruited_VBN from_IN local_JJ and_CC national_JJ
          advertising_NN ._. To_TO be_VB included_VBN in_IN the_DT study_NN ,_, adolescents_NNS and_CC
          adults_NNS had_VBD to_TO meet_VB the_DT following_JJ criteria_NNS :_: 1_LS )_) be_VB of_IN
          Caucasian_NNP ethnicity_NN ;_: 2_LS )_) be_VB free_JJ from_IN diagnosed_VBN endocrine_NN
          conditions_NNS that_WDT could_MD lead_VB to_TO obesity_NN ,_, and_CC 3_LS )_) not_RB taking_VBG
          any_DT medication_NN affecting_VBG body_NN weight_NN ._. They_PRP were_VBD selected_VBN
          for_IN the_DT study_NN on_IN the_DT basis_NN of_IN their_PRP$ body_NN mass_NN index_NN ._.
          Standing_VBG height_NN was_VBD measured_VBN with_IN a_DT wall-mounted_JJ tape_NN ,_,
          and_CC weight_NN was_VBD measured_VBN with_IN the_DT same_JJ standard_JJ balance_NN
          scale_NN ._.
          Adolescents_NNP were_VBD classified_VBN according_VBG to_TO BMI_NNP ;_: ≥_NN 85_CD
          thpercentile_NN as_IN overweight_NN ,_, and_CC ≥_NN 95_CD thpercentile_NN for_IN age_NN
          and_CC sex_NN as_IN obese_NN [_NN 29_CD 30_CD 31_CD 32_CD ]_NN ._. Recent_JJ workshops_NNS
          concluded_VBD that_IN the_DT BMI_NNP has_VBZ been_VBN validated_JJ by_IN studies_NNS on_IN
          total_JJ body_NN fat_JJ [_NN 32_CD ]_NN ._. The_DT standards_NNS used_VBN to_TO identify_VB
          overweight_NN and_CC obesity_NN in_IN children_NNS and_CC adolescents_NNS should_MD
          agree_VB with_IN the_DT standards_NNS used_VBN to_TO identify_VB grade_NN 1_CD and_CC
          grade_NN 2_CD overweight_NN (_( BMI_NNP of_IN 25_CD and_CC 30_CD ,_, respectively_RB )_) in_IN
          adults_NNS [_NN 33_CD ]_NN ._. Adolescents_NNP with_IN a_DT BMI_NNP <_NN 85_CD
          thpercentile_NN were_VBD classified_VBN as_IN controls_NNS (_( Group_NNP 1_LS )_) ,_, Group_NNP
          2_CD were_VBD overweight_NN (_( BMI_NNP >_NN 85_CD thpercentile_NN and_CC <_NN 95_CD
          thpercentile_NN )_) and_CC group_NN 3_CD were_VBD obese_NN (_( BMI_NNP ≥_NN 95_CD
          thpercentile_NN )_) ._. Adults_NNS with_IN a_DT BMI_NNP <_NN 25_CD were_VBD classified_VBN
          as_IN controls_NNS ,_, between_IN 25_CD and_CC 30_CD as_IN overweight_NN and_CC ≥_NN 30_CD as_IN
          obese_NN ._. Sexes_NNP were_VBD grouped_VBN separately_RB ._.
          WC_NNP :_: AC_NNP was_VBD calculated_VBN from_IN the_DT ratio_NN of_IN waist_NN
          circumference_NN to_TO arm_VB circumference_NN and_CC used_VBN as_IN a_DT measured_VBN
          of_IN fat_JJ distribution_NN analogous_JJ to_TO waist_NN to_TO hip_NN ratio_NN ,_, on_IN
          the_DT assumption_NN that_IN a_DT higher_JJR ratio_NN of_IN waist_NN to_TO arm_VB
          circumference_NN is_VBZ an_DT indicator_NN of_IN a_DT more_RBR central_JJ pattern_NN
          of_IN adiposity_NN ._. We_PRP used_VBD this_DT measure_NN in_IN preference_NN to_TO waist_NN
          to_TO hip_NN ratio_NN ,_, because_IN a_DT study_NN which_WDT determined_VBD peripheral_JJ
          and_CC abdominal_NN adipose_NN tissue_NN content_NN in_IN children_NNS using_VBG
          magnetic_JJ resonance_NN imaging_NN found_VBD that_IN WC_NNP :_: AC_NNP correlated_JJ
          positively_RB with_IN intra-abdominal_JJ adipose_NN tissue_NN (_( r_LS ±_NN 0_CD ._. 63_CD ,_,
          P_NN =_SYM 0_CD ._. 001_CD )_) while_IN waist_NN to_TO hip_NN ratio_NN did_VBD not_RB (_( r_LS =_SYM 0_CD ._. 11_CD )_) [_NN
          34_CD ]_NN ._. Two_CD other_JJ indices_NNS of_IN central_JJ adiposity_NN were_VBD
          calculated_VBN from_IN skinfolds_NNS :_: Central-peripheral_NNP (_( CPR_NNP )_) as_IN
          subscapular_NN skinfold_NN +_NN suprailliac_NN skinfold_NN )_) /_NN (_( triceps_NNS
          skinfold_NN +_NN thigh_NN skinfold_NN )_) and_CC ratio_NN of_IN subscapular_NN to_TO
          triceps_NNS skinfold_NN (_( STR_NNP )_) ._. STR_NNP is_VBZ an_DT index_NN of_IN relative_JJ
          distribution_NN of_IN central_JJ subcutaneous_JJ adiposity_NN ._. The_DT sum_NN
          of_IN the_DT four_CD skinfolds_NNS (_( SUM_NNP )_) was_VBD calculated_VBN from_IN triceps_NNS ,_,
          subscapular_NN ,_, suprailliac_NN and_CC thigh_NN skinfolds_NNS in_IN the_DT total_JJ
          sample_NN ._. The_DT SUM_NNP provides_VBZ a_DT single_JJ measure_NN of_IN subcutaneous_JJ
          adiposity_NN ._. Anthropometric_NNP measurements_NNS were_VBD done_VBN by_IN the_DT
          same_JJ experienced_VBN evaluator_NN to_TO reduce_VB variability_NN which_WDT
          was_VBD measured_VBN at_IN less_JJR than_IN 0_CD ._. 5_CD %_NN ._.
          Genital_NNP development_NN was_VBD evaluated_VBN with_IN the_DT criteria_NNS of_IN
          Tanner_NNP [_NN 35_CD ]_NN ,_, and_CC was_VBD performed_VBN with_IN a_DT questionnaire_NN
          and_CC physical_JJ exam_NN by_IN an_DT experienced_VBN physician_NN ,_, in_IN which_WDT
          stage_VBP 1_CD is_VBZ prepubertal_NN ,_, stage_NN 2_CD is_VBZ initial_JJ development_NN of_IN
          the_DT genitalia_NN ,_, stages_NNS 3_CD and_CC 4_CD are_VBP intermediate_JJ ,_, and_CC stage_NN
          5_CD is_VBZ mature_VBP ._. Stage_NN of_IN sexual_JJ maturation_NN in_IN the_DT girls_NNS was_VBD
          determined_VBN on_IN the_DT basis_NN of_IN a_DT combination_NN of_IN menarcheal_NN
          status_NN and_CC breast_NN and_CC pubic_JJ hair_NN development_NN [_NN 36_CD ]_NN ._. The_DT
          stages_NNS of_IN sexual_JJ maturation_NN were_VBD performed_VBN with_IN a_DT
          questionnaire_NN and_CC physical_JJ exam_NN done_VBN by_IN an_DT experienced_VBN
          physician_NN as_IN follow_VB :_: premenarcheal_NN with_IN no_DT secondary_JJ
          sexual_JJ development_NN (_( stage_NN 1_LS )_) ._. Premenarcheal_NNP with_IN some_DT
          secondary_JJ sexual_JJ development_NN (_( stage_NN 2_LS )_) ;_: premenarcheal_NN at_IN
          the_DT time_NN of_IN study_NN but_CC attained_VBN menarche_NN within_IN 6_CD months_NNS
          (_( stage_NN 3_LS )_) ;_: postmenarcheal_NN with_IN secondary_JJ sexual_JJ
          development_NN not_RB yet_RB mature_VB (_( stage_NN 4_LS )_) ;_: and_CC postmenarcheal_NN
          with_IN secondary_JJ sexual_JJ development_NN (_( stage_NN 5_LS )_) ._.
          The_DT subjects_NNS were_VBD instructed_VBN to_TO arrive_VB to_TO the_DT clinic_NN
          at_IN 8_CD :_: 00_CD AM_NNP after_IN 12_CD -_: hour_NN overnight_JJ fast_RB ._. BMI_NNP was_VBD measured_VBN
          and_CC a_DT venous_JJ blood_NN sample_NN was_VBD taken_VBN followed_VBN by_IN a_DT
          breakfast_NN ._. Fasting_NNP blood_NN samples_NNS were_VBD stored_VBN at_IN 4_CD C_NNP ._. Serum_NNP
          glucose_NN and_CC insulin_NN levels_NNS and_CC lipid_NN profile_NN were_VBD
          determined_VBN ._. They_PRP completed_VBD a_DT questionnaire_NN on_IN risk_NN
          factors_NNS for_IN atherosclerosis_NNS including_VBG family_NN history_NN of_IN
          coronopathy_NN ,_, smoking_NN ,_, high_JJ blood_NN pressure_NN ,_, personal_JJ
          history_NN of_IN coronopathy_NN or_CC myocardial_NN infarct_NN ,_, history_NN of_IN
          cerebrovascular_NN disease_NN or_CC occlusive_JJ peripheral_JJ disease_NN ._.
          Most_JJS overweight_NN and_CC obese_NN subjects_NNS had_VBD at_IN least_JJS two_CD risk_NN
          factors_NNS for_IN atherosclerosis_NNS ._.
          The_DT diagnostic_JJ criteria_NNS for_IN glucose_NN profile_NN were_VBD those_DT
          approved_VBN by_IN the_DT American_NNP Diabetes_NNP Association_NNP [_NN 37_CD ]_NN ._.
          Diabetes_NNP is_VBZ defined_VBN as_IN a_DT fasting_VBG serum_NN glucose_NN equal_JJ or_CC
          higher_JJR than_IN 7_CD mmol_NN /_NN L_NNP (_( 126_CD mg_NN /_NN dl_NN )_) and_CC impaired_VBN fasting_VBG
          glucose_NN with_IN values_NNS between_IN 6_CD ._. 0_CD and_CC 7_CD ._. 0_CD mmol_NN /_NN L_NNP ._. Subjects_NNP
          with_IN high_JJ fasting_VBG glucose_NN levels_NNS were_VBD referred_VBN to_TO their_PRP$
          own_JJ physicians_NNS for_IN further_JJ clinical_JJ evaluation_NN ._.
          Lipid_NNP profile_NN was_VBD also_RB performed_VBN on_IN the_DT fasting_VBG blood_NN
          sample_NN ._. The_DT blood_NN lipid_NN variables_NNS investigated_VBN were_VBD
          triglyceride_NN (_( TRG_NNP )_) ,_, total_JJ cholesterol_NN (_( TC_NNP )_) ,_, high-density_JJ
          lipoprotein_NN (_( HDL_NNP )_) cholesterol_NN concentrations_NNS ,_, low-density_NN
          lipoproteins_NNS (_( LDL_NNP )_) cholesterol_NN concentrations_NNS and_CC the_DT
          ratio_NN of_IN total_JJ :_: HDL_NNP cholesterol_NN (_( T_NN :_: HDLC_NNP )_) [_NN 38_CD ]_NN ._. All_DT
          biochemical_JJ measurements_NNS were_VBD performed_VBN in_IN an_DT accredited_JJ
          hospital_NN laboratory_NN ._.
        
        
          Study_NNP 2_CD
          The_DT second_JJ investigation_NN was_VBD designed_VBN as_IN a_DT
          retrospective-prospective_JJ longitudinal_NN study_NN from_IN 1974_CD to_TO
          2000_CD and_CC was_VBD performed_VBN from_IN hospitals_NNS associated_VBN with_IN
          Montreal_NNP and_CC McGill_NNP Universities_NNS ._. This_DT study_NN was_VBD
          conducted_VBN to_TO determine_VB the_DT age_NN of_IN apparition_NN of_IN abnormal_JJ
          glucose_NN and_CC lipid_NN profiles_NNS in_IN a_DT group_NN of_IN overweight_NN and_CC
          obese_NN young_JJ Caucasians_NNP adults_NNS presenting_VBG abnormal_JJ glucose_NN
          and_CC /_NN or_CC lipid_NN profiles_NNS ._. The_DT study_NN was_VBD performed_VBN from_IN chart_NN
          review_NN of_IN participants_NNS ._. 2000_CD charts_NNS were_VBD pre-selected_JJ by_IN
          the_DT archivists_NNS ._. To_TO be_VB included_VBN in_IN the_DT study_NN ,_, young_JJ adults_NNS
          had_VBD to_TO meet_VB the_DT following_JJ criteria_NNS :_: 1_LS )_) be_VB of_IN Caucasian_NNP
          ethnicity_NN ;_: 2_LS )_) be_VB between_IN the_DT ages_NNS of_IN 32_CD -_: 38_CD y_NN ;_: 3_LS )_) be_VB free_JJ
          from_IN diagnosed_VBN endocrine_NN conditions_NNS that_WDT could_MD have_VB led_VBN
          to_TO obesity_NN ,_, 4_LS )_) not_RB having_VBG taken_VBN any_DT medication_NN affecting_VBG
          body_NN weight_NN ,_, 5_LS )_) presenting_VBG a_DT BMI_NNP ≥_NN 25_CD at_IN adult_NN age_NN ;_: 6_CD )_)
          presenting_VBG abnormal_JJ glucose_NN and_CC /_NN or_CC lipid_NN profiles_NNS ;_: 7_CD )_)
          presenting_VBG at_IN least_JJS 2_CD risk_NN factors_NNS for_IN cardiovascular_JJ
          diseases_NNS as_IN explained_VBN earlier_RBR ,_, and_CC having_VBG been_VBN seen_VBN by_IN
          their_PRP$ physicians_NNS between_IN 1974_CD to_TO 2000_CD ._. Among_IN the_DT 2000_CD
          charts_NNS ,_, only_RB 128_CD males_NNS and_CC 112_CD females_NNS were_VBD having_VBG
          pertinent_JJ data_NNS at_IN the_DT different_JJ 7_CD age-groups_JJ ,_, permitting_VBG
          longitudinal_NN study_NN of_IN all_PDT the_DT subjects_NNS used_VBN in_IN this_DT
          study_NN ._. These_DT charts_NNS were_VBD reviewed_VBN by_IN 2_CD reviwers_NNS ._. A_DT sample_NN
          of_IN 20_CD charts_NNS were_VBD reviewed_VBN by_IN the_DT two_CD reviewers_NNS to_TO
          determine_VB variability_NN between_IN reviewers_NNS ._. The_DT inter-chart_JJ
          reviewer_NN differences_NNS was_VBD less_JJR than_IN 0_CD ._. 2_CD %_NN ._. Data_NNS from_IN the_DT
          subjects_NNS were_VBD presented_VBN by_IN specific_JJ age_NN group_NN ,_, which_WDT we_PRP
          think_VBP may_MD approximate_JJ the_DT criteria_NNS of_IN Tanner_NNP [_NN 35_CD ]_NN for_IN
          genital_JJ development_NN ._. WC_NNP :_: AC_NNP ratio_NN was_VBD removed_VBN from_IN the_DT
          anthropometric_JJ measurements_NNS because_IN the_DT concept_NN of_IN waist_NN
          circumference_NN ,_, waist_NN to_TO hip_NN ratio_NN or_CC waist_NN circumference_NN
          to_TO arm_VB circumference_NN was_VBD unknown_JJ or_CC not_RB used_VBN to_TO quantify_VB
          central_JJ adiposity_NN ._.
        
        
          Statistical_NNP procedures_NNS
          SAS_NNP PROC_NNP MIXED_NNP version_NN 6_CD ._. 11_CD (_( SAS_NNP Institute_NNP ,_, Cary_NNP ,_,
          North_NNP Carolina_NNP )_) was_VBD used_VBN to_TO analyze_VB longitudinal_NN and_CC
          correlated_JJ data_NNS ._. The_DT analyses_NNS were_VBD interpreted_VBN using_VBG P_NN
          <_NN 0_CD ._. 01_CD as_IN the_DT level_NN of_IN significance_NN ._. An_DT unpaired_JJ
          T-_NNP test_NN was_VBD used_VBN to_TO analyze_VB the_DT difference_NN between_IN male_JJ
          and_CC female_JJ for_IN each_DT variables_NNS measured_VBN at_IN each_DT Tanner_NNP
          stages_NNS ._. Pearson_NNP correlations_NNS were_VBD computed_JJ to_TO evaluate_VB
          the_DT relationship_NN between_IN specific_JJ continuous_JJ variables_NNS ._.
          Odds_NNS ratios_NNS were_VBD used_VBN to_TO quantify_VB risk_NN in_IN our_PRP$
          population_NN ._.
        
      
      
        Results_NNS
        
          Study_NNP 1_CD
          Table_NNP 1_CD shows_VBZ the_DT main_JJ anthropometric_JJ measurements_NNS of_IN
          our_PRP$ study_NN population_NN ._. Pubertal_NNP status_NN was_VBD appropriate_JJ for_IN
          age_NN in_IN all_DT subjects_NNS ;_: all_DT girls_NNS over_IN 14_CD y_NN had_VBD reached_VBN
          menarche_NN and_CC all_DT boys_NNS over_IN 14_CD y_NN had_VBD Tanner_NNP Stage_NNP grades_NNS
          of_IN 3_CD or_CC more_JJR ._. The_DT distribution_NN of_IN obese_NN and_CC overweight_NN
          adolescents_NNS in_IN our_PRP$ study_NN did_VBD not_RB differ_VB from_IN that_DT
          expected_VBD in_IN an_DT average_JJ North_JJ American_JJ population_NN ._. As_IN
          defined_VBN in_IN methods_NNS WC_NNP :_: AC_NNP ratio_NN which_WDT is_VBZ an_DT indicator_NN of_IN
          central_JJ adiposity_NN was_VBD significantly_RB higher_JJR in_IN both_DT (_( P_NN
          <_NN 0_CD ._. 01_CD )_) overweight_NN and_CC (_( P_NN <_NN 0_CD ._. 001_CD )_) obese_NN
          adolescents_NNS in_IN comparison_NN with_IN controls_NNS ,_, either_CC in_IN
          adolescents_NNS of_IN different_JJ Tanner_NNP 's_POS stages_NNS or_CC adults_NNS of_IN
          both_DT sexes_NNS ._. The_DT CPR_NNP value_NN which_WDT is_VBZ representative_NN of_IN
          central-peripheral_JJ obesity_NN was_VBD also_RB significantly_RB higher_JJR
          (_( P_NN <_NN 0_CD ._. 01_CD )_) in_IN both_DT overweight_NN and_CC (_( P_NN <_NN 0_CD ._. 001_CD )_) obese_NN
          adolescents_NNS ._. The_DT same_JJ is_VBZ true_JJ for_IN the_DT STR_NNP and_CC SUM_NNP values_NNS ._.
          For_IN all_PDT the_DT anthropometric_JJ measurements_NNS there_EX were_VBD no_DT
          significant_JJ differences_NNS between_IN sexes_NNS ._.
          Table_NNP 2_CD indicates_VBZ that_IN the_DT prevalence_NN of_IN impaired_VBN
          glucose_NN and_CC lipid_NN profiles_NNS were_VBD highest_JJS among_IN those_DT with_IN
          a_DT BMI_NNP above_IN the_DT 95_CD th_NN ._. The_DT prevalence_NN of_IN impaired_VBN fasting_VBG
          glucose_NN is_VBZ already_RB significant_JJ at_IN Tanner_NNP stage_NN 1_CD with_IN
          percentage_NN prevalence_NN of_IN 11_CD ._. 1_LS %_NN and_CC 44_CD ._. 1_LS %_NN for_IN overweight_NN
          and_CC obese_NN subjects_NNS respectively_RB ._. The_DT prevalence_NN was_VBD
          significantly_RB higher_JJR in_IN both_DT (_( P_NN <_NN 0_CD ._. 01_CD )_) overweight_NN and_CC
          (_( P_NN <_NN 0_CD ._. 001_CD )_) obese_NN adolescents_NNS in_IN comparison_NN with_IN
          controls_NNS ,_, either_CC in_IN adolescents_NNS of_IN different_JJ Tanner_NNP 's_POS
          stages_NNS or_CC adults_NNS of_IN both_DT sexes_NNS ._. The_DT prevalence_NN of_IN
          impaired_VBN fasting_VBG glucose_NN did_VBD not_RB differ_VB significantly_RB
          between_IN adolescents_NNS and_CC adults_NNS ,_, either_CC in_IN male_JJ or_CC female_JJ ._.
          Adolescents_NNP with_IN BMI_NNP exceeding_VBG the_DT 85_CD thpercentile_NN are_VBP at_IN
          increased_VBN risk_NN of_IN being_VBG classified_VBN as_IN having_VBG diabetes_NN or_CC
          impaired_VBN fasting_VBG glucose_NN ._. Also_RB the_DT prevalence_NN of_IN lipid_NN
          profile_NN abnormalities_NNS was_VBD highest_JJS among_IN those_DT above_IN the_DT
          95_CD thpercentile_NN for_IN BMI_NNP ._. Adolescents_NNP with_IN BMI_NNP exceeding_VBG
          the_DT 85_CD thpercentile_NN are_VBP at_IN increased_VBN risk_NN of_IN having_VBG
          abnormal_JJ lipid_NN profiles_NNS ._. Again_RB ,_, the_DT difference_NN between_IN
          the_DT three_CD groups_NNS was_VBD already_RB present_JJ at_IN Tanner_NNP stage_NN 1_CD ._.
          The_DT presence_NN of_IN an_DT abnormal_JJ lipid_NN profile_NN was_VBD observed_VBN
          from_IN Tanner_NNP stages_NNS III_NNP and_CC above_IN ._.
          Sensitivity_NNP refers_VBZ to_TO the_DT percentage_NN of_IN obese_NN or_CC
          overweight_NN participants_NNS who_WP were_VBD correctly_RB predicted_VBN to_TO
          be_VB at_IN risk_NN for_IN either_DT glucose_NN or_CC lipid_NN profiles_NNS
          abnormalities_NNS ._. Specificity_NNP refers_VBZ to_TO the_DT percentage_NN of_IN
          participants_NNS who_WP were_VBD correctly_RB predicted_VBN to_TO be_VB in_IN the_DT
          remaining_VBG groups_NNS ._. BMI_NNP >_NN 85_CD thpercentile_NN were_VBD chosen_VBN as_IN
          cutoff_NN point_NN for_IN identifying_VBG overweight_NN adolescents_NNS and_CC
          BMI_NNP <_NN 85_CD thpercentile_NN were_VBD considered_VBN as_IN normal_JJ
          subjects_NNS ._. Table_NNP 3_CD shows_VBZ that_IN the_DT sensitivity_NN and_CC
          specificity_NN to_TO predict_VB impaired_VBN fasting_VBG glucose_NN at_IN Tanner_NNP
          stages_NNS III_NNP and_CC above_IN were_VBD at_IN least_JJS 60_CD %_NN and_CC 80_CD %_NN ,_,
          respectively_RB ._. With_IN use_NN of_IN this_DT cutoff_NN point_NN ,_, the_DT odds_NNS
          ratio_NN of_IN being_VBG at_IN risk_NN for_IN impaired_VBN fasting_VBG glucose_NN
          varied_VBD from_IN 11_CD ._. 7_CD to_TO 23_CD ._. 7_CD for_IN males_NNS and_CC females_NNS ._.
          Table_NNP 4_CD shows_VBZ that_IN the_DT sensitivity_NN and_CC specificity_NN to_TO
          predict_VB an_DT impaired_VBN lipid_NN profiles_NNS at_IN Tanner_NNP stages_NNS III_NNP
          and_CC above_IN were_VBD from_IN 47_CD ._. 5_LS %_NN to_TO 83_CD %_NN (_( males_NNS )_) and_CC from_IN 84_CD ._. 8_CD %_NN
          to_TO 91_CD ._. 2_LS %_NN (_( females_NNS )_) ,_, respectively_RB ._. Using_VBG a_DT BMI_NNP at_IN the_DT 85_CD
          thpercentile_NN as_IN a_DT cutoff_NN point_NN ,_, the_DT odds_NNS ratio_NN for_IN
          impaired_VBN lipid_NN profiles_NNS varied_VBD from_IN 9_CD ._. 1_CD to_TO 15_CD ._. 2_LS for_IN males_NNS
          and_CC females_NNS ._.
          The_DT associations_NNS between_IN anthropometric_JJ measurements_NNS ,_,
          fasting_VBG glucose_NN and_CC insulin_NN levels_NNS ,_, and_CC lipid_NN profiles_NNS ,_,
          at_IN each_DT Tanner_NNP stage_NN are_VBP presented_VBN in_IN Tables_NNP 5_CD and_CC
          6_CD respectively_RB ,_, with_IN (_( P_NN <_NN 0_CD ._. 01_CD and_CC less_JJR )_) for_IN each_DT
          group_NN ._. Regression_NNP analyses_NNS were_VBD not_RB required_VBN to_TO establish_VB
          significance_NN ._.
        
        
          Study_NNP 2_CD
          Table_NNP 7_CD shows_VBZ the_DT main_JJ anthropometric_JJ measurements_NNS of_IN
          our_PRP$ study_NN population_NN at_IN 7_CD different_JJ interval_NN age_NN groups_NNS
          from_IN 9_CD to_TO 38_CD years_NNS old_JJ ._. The_DT BMI_NNP adjusted_VBD for_IN age_NN and_CC sex_NN
          was_VBD appropriate_JJ at_IN each_DT interval_NN age_NN group_NN ._. CPR_NNP STR_NNP and_CC
          SUM_NNP were_VBD significantly_RB increased_VBN (_( P_NN <_NN 0_CD ._. 01_CD )_) with_IN age_NN
          corresponding_JJ with_IN a_DT higher_JJR fat_JJ mass_NN with_IN growth_NN ._. For_IN all_PDT
          the_DT anthropometric_JJ measurements_NNS there_EX were_VBD no_DT significant_JJ
          gender_NN differences_NNS ._.
          Table_NNP 8_CD presents_VBZ the_DT incidence_NN of_IN impaired_VBN glucose_NN and_CC
          lipid_NN profile_NN between_IN age_NN groups_NNS ._. The_DT incidences_NNS of_IN
          impaired_VBN glucose_NN and_CC lipid_NN profiles_NNS were_VBD already_RB high_JJ at_IN
          the_DT first_JJ age_NN group_NN with_IN incidences_NNS of_IN approximately_RB 30_CD %_NN
          for_IN both_DT ._. The_DT incidence_NN increases_NNS progressively_RB with_IN
          age_NN ._.
          Fasting_NNP plasma_NN glucose_NN level_NN (_( results_NNS not_RB shown_VBN )_) ,_,
          HbA_NNP 1_CD c_SYM and_CC fasting_VBG plasma_NN insulin_NN levels_NNS were_VBD
          significantly_RB increased_VBN (_( P_NN <_NN 0_CD ._. 01_CD )_) through_IN puberty_NN and_CC
          growth_NN ._. There_EX were_VBD no_DT significant_JJ differences_NNS between_IN
          sexes_NNS ._. TRG_NNP ,_, TC_NNP ,_, LDL_NNP and_CC T_NN :_: HDLC_NNP were_VBD also_RB significantly_RB
          increased_VBN (_( P_NN <_NN 0_CD ._. 01_CD )_) with_IN growth_NN ._. The_DT reverse_NN was_VBD
          observed_VBN for_IN HDL_NNP ._.
          BMI_NNP values_NNS at_IN the_DT 85_CD thpercentile_NN for_IN 13_CD -_: 15_CD year_NN old_JJ
          group_NN were_VBD chosen_VBN as_IN cutoff_NN points_NNS for_IN identifying_VBG
          overweight_NN at_IN age_NN 35_CD y_NN ._. The_DT sensitivities_NNS were_VBD 77_CD ._. 7_CD %_NN and_CC
          83_CD ._. 3_LS %_NN ,_, and_CC the_DT specificities_NNS 80_CD ._. 0_CD %_NN and_CC 80_CD ._. 0_CD %_NN ,_, for_IN males_NNS
          and_CC females_NNS respectively_RB ._. With_IN use_NN of_IN the_DT cutoff_NN point_NN of_IN
          the_DT 85_CD thpercentile_NN at_IN this_DT age_NN group_NN ,_, the_DT odds_NNS ratios_NNS
          for_IN overweight_NN at_IN age_NN 35_CD y_NN were_VBD 12_CD ._. 8_CD for_IN males_NNS and_CC 20_CD ._. 0_CD
          for_IN females_NNS (_( Table_NNP 9_CD )_) ._.
          Table_NNP 10_CD presents_VBZ the_DT sensitivity_NN ,_, specificity_NN and_CC odds_NNS
          ratios_NNS for_IN the_DT selected_VBN cutoff_NN point_NN for_IN predicting_VBG
          impaired_VBN fasting_VBG glucose_NN (_( IFG_NNP )_) values_NNS at_IN the_DT 85_CD
          thpercentile_NN at_IN 13_CD -_: 15_CD year_NN old_JJ group_NN ,_, at_IN age_NN 35_CD ._. The_DT
          sensitivities_NNS were_VBD 77_CD ._. 8_CD %_NN and_CC 71_CD ._. 4_LS %_NN ,_, and_CC the_DT specificities_NNS
          76_CD ._. 4_LS %_NN and_CC 77_CD ._. 6_CD %_NN for_IN males_NNS and_CC females_NNS respectively_RB ._. The_DT
          odds_NNS ratios_NNS for_IN abnormal_JJ IFG_NNP at_IN age_NN 35_CD y_NN were_VBD 11_CD ._. 3_LS for_IN
          males_NNS and_CC 8_CD ._. 6_CD for_IN females_NNS ._.
          Table_NNP 11_CD presents_VBZ the_DT sensitivity_NN ,_, specificity_NN and_CC odds_NNS
          ratios_NNS for_IN predicting_VBG impaired_VBN lipid_NN profiles_NNS (_( ILP_NNP )_) at_IN
          the_DT 85_CD thpercentile_NN at_IN 13_CD -_: 15_CD year_NN old_JJ group_NN ,_, for_IN age_NN 35_CD ._.
          The_DT sensitivities_NNS were_VBD 80_CD ._. 0_CD %_NN and_CC 75_CD %_NN ,_, and_CC the_DT
          specificities_NNS 77_CD ._. 7_CD %_NN and_CC 79_CD ._. 2_LS %_NN ,_, for_IN males_NNS and_CC females_NNS
          respectively_RB ._. With_IN use_NN of_IN the_DT cutoff_NN point_NN of_IN the_DT 85_CD
          thpercentile_NN at_IN 13_CD -_: 15_CD year_NN old_JJ group_NN ,_, the_DT odds_NNS ratios_NNS of_IN
          ILP_NNP at_IN age_NN 35_CD y_NN were_VBD 14_CD ._. 0_CD for_IN males_NNS and_CC 11_CD ._. 4_LS for_IN
          females_NNS ._.
        
      
      
        Discussion_NNP
        
          Study_NNP 1_CD
          The_DT rationale_NN underlying_VBG this_DT part_NN of_IN the_DT study_NN is_VBZ
          that_IN the_DT stage_NN of_IN sexual_JJ maturation_NN is_VBZ an_DT important_JJ
          variable_NN in_IN applying_VBG anthropometric_JJ measurements_NNS as_IN
          predictors_NNS of_IN risk_NN for_IN cardiovascular_JJ diseases_NNS ._. On_IN
          average_JJ ,_, BMI_NNP seems_VBZ to_TO increase_VB with_IN stage_NN of_IN genital_JJ
          maturation_NN in_IN boys_NNS relative_JJ to_TO fatness_NNS ,_, and_CC then_RB ,_, in_IN
          contrast_NN ,_, decreases_NNS in_IN the_DT later_JJ stages_VBZ of_IN maturation_NN
          reflecting_VBG the_DT rapid_JJ growth_NN of_IN fat_JJ free_JJ mass_NN with_IN
          puberty_NN ._. BMI_NNP in_IN girls_NNS also_RB increases_VBZ with_IN stage_NN of_IN sexual_JJ
          maturation_NN ,_, but_CC relative_JJ fatness_NNS is_VBZ variable_JJ ,_, especially_RB
          in_IN girls_NNS who_WP just_RB attaining_VBG menarche_NN (_( stage_NN III_NNP )_) ._. To_TO
          obviate_VB this_DT bias_NN ,_, we_PRP preselected_JJ our_PRP$ subjects_NNS according_VBG
          to_TO their_PRP$ BMI_NNP ._. For_IN instance_NN a_DT BMI_NNP ≥_NN 85_CD thpercentile_NN (_( for_IN
          age_NN and_CC sex_NN )_) was_VBD classified_VBN as_IN being_VBG overweight_NN ,_, and_CC
          those_DT with_IN a_DT BMI_NNP ≥_NN 95_CD thpercentile_NN as_IN obese_NN [_NN 29_CD 30_CD 31_CD 32_CD
          ]_NN ._. Recent_JJ workshops_NNS concluded_VBD that_IN the_DT BMI_NNP is_VBZ an_DT index_NN
          of_IN choice_NN for_IN evaluating_VBG obesity_NN in_IN adolescents_NNS ,_, because_IN
          it_PRP has_VBZ been_VBN validated_JJ by_IN studies_NNS of_IN total_JJ body_NN fat_JJ [_NN 32_CD ]_NN
          ._. The_DT criteria_NNS used_VBN to_TO identify_VB overweight_NN and_CC obesity_NN in_IN
          children_NNS and_CC adolescents_NNS agree_VBP with_IN those_DT used_VBN for_IN grade_NN
          1_CD and_CC grade_NN 2_CD overweight_NN (_( BMI_NNP of_IN 25_CD +_NN and_CC 30_CD +_NN ,_,
          respectively_RB )_) in_IN adults_NNS [_NN 33_CD ]_NN ._. Using_VBG a_DT representative_NN
          sample_NN from_IN the_DT general_JJ North_JJ American_NNP Caucasian_NNP
          population_NN ,_, we_PRP demonstrate_VBP that_IN the_DT BMI_NNP is_VBZ also_RB a_DT good_JJ
          indicator_NN for_IN obesity_NN in_IN adolescents_NNS ,_, however_RB the_DT
          readily-measured_JJ WC_NNP :_: AC_NNP ,_, CPR_NNP ,_, and_CC STR_NNP ,_, indices_NNS of_IN central_JJ
          obesity_NN ,_, and_CC SUM_NNP ,_, a_DT single_JJ measure_NN of_IN subcutaneous_JJ
          adiposity_NN ,_, are_VBP stronger_JJR predictor_NN of_IN both_DT fasting_VBG glucose_NN
          and_CC insulin_NN levels_NNS and_CC lipid_NN profiles_NNS ,_, than_IN BMI_NNP ._. We_PRP also_RB
          demonstrated_VBD that_IN each_DT anthropometric_JJ variable_JJ taken_VBN
          separately_RB can_MD significantly_RB predict_VB fasting_VBG glucose_NN and_CC
          insulin_NN levels_NNS and_CC lipid_NN profile_NN in_IN adolescents_NNS of_IN both_DT
          sexes_NNS with_IN a_DT probability_NN of_IN P_NN <_NN 0_CD ._. 01_CD ._. Our_PRP$ results_NNS are_VBP
          in_IN accordance_NN with_IN others_NNS of_IN children_NNS aged_VBN 5_CD and_CC 16_CD ,_, in_IN
          whom_WP ,_, indicators_NNS of_IN fatness_NNS such_JJ as_IN weight-for-height_JJ ,_,
          BMI_NNP and_CC skinfold_NN thicknesses_NNS have_VBP been_VBN associated_VBN with_IN
          higher_JJR total_JJ and_CC LDL_NNP cholesterol_NN ,_, lower_JJR HDL_NNP cholesterol_NN ,_,
          and_CC higher_JJR triglyceride_NN concentrations_NNS [_NN 40_CD 41_CD 42_CD 43_CD ]_NN
          ._.
          Our_PRP$ overweight_NN and_CC obese_NN adolescents_NNS had_VBD higher_JJR
          fasting_VBG glucose_NN ,_, and_CC insulin_NN levels_NNS for_IN BMI_NNP than_IN subjects_NNS
          with_IN BMI_NNP in_IN the_DT healthy_JJ range_NN ._. Furtheremore_NNP ,_, the_DT
          prevalence_NN of_IN obesity_NN was_VBD comparable_JJ between_IN boys_NNS and_CC
          girls_NNS ._. In_IN both_DT sexes_NNS the_DT prevalence_NN of_IN diabetes_NN and_CC
          impaired_VBN fasting_VBG glucose_NN increased_VBD relative_JJ to_TO
          chronological_JJ age_NN in_IN both_DT overweight_NN (_( 
          P_NN <_NN 0_CD ._. 01_CD )_) and_CC obese_NN subjects_NNS (_( 
          P_NN <_NN 0_CD ._. 001_CD )_) ._. Previous_JJ study_NN in_IN
          Aboriginal_NNP children_NNS recognized_VBN to_TO be_VB at_IN high_JJ risk_NN for_IN
          type_NN II_NNP diabetes_NN has_VBZ shown_VBN that_DT obesity_NN is_VBZ associated_VBN
          with_IN high_JJ fasting_VBG glucose_NN and_CC fasting_VBG insulin_NN levels_NNS ._.
          They_PRP also_RB demonstrated_VBD that_IN children_NNS with_IN BMI_NNP exceeding_VBG
          the_DT 85_CD thpercentile_NN are_VBP at_IN increased_VBN risk_NN of_IN diabetes_NN or_CC
          impaired_VBN fasting_VBG glucose_NN ,_, odds_NNS ratio_NN of_IN 5_CD ._. 1_CD with_IN 95_CD %_NN
          coefficient_NN interval_NN 1_CD ._. 5_CD ,_, 17_CD ._. 0_CD [_NN 39_CD ]_NN ._. With_IN use_NN of_IN the_DT
          cutoff_NN point_NN of_IN the_DT 85_CD thpercentile_NN we_PRP demonstrated_VBD that_IN
          adolescents_NNS of_IN Tanner_NNP stage_NN III_NNP and_CC higher_JJR ,_, of_IN both_DT
          sexes_NNS ,_, are_VBP at_IN increased_VBN risk_NN of_IN having_VBG impaired_VBN fasting_VBG
          glucose_NN ,_, with_IN odds_NNS ratios_NNS of_IN 11_CD ._. 7_CD and_CC higher_JJR ._.
          Our_PRP$ overweight_NN and_CC obese_NN adolescents_NNS had_VBD higher_JJR TC_NNP ,_,
          LDL_NNP ,_, TRG_NNP and_CC lower_JJR HDL_NNP values_NNS which_WDT correlated_JJ with_IN BMI_NNP ,_,
          and_CC other_JJ measures_NNS of_IN fatness_NNS ._. In_IN both_DT sexes_NNS the_DT
          prevalence_NN of_IN impaired_VBN lipid_NN profile_NN increased_VBD relative_JJ
          to_TO chronological_JJ age_NN in_IN both_DT overweight_NN (_( 
          P_NN <_NN 0_CD ._. 01_CD )_) and_CC obese_NN subjects_NNS (_( 
          P_NN <_NN 0_CD ._. 001_CD )_) l_NN ._. Adolescents_NNP of_IN
          both_DT sexes_NNS ,_, with_IN BMI_NNP ≥_NN 85_CD thare_NN at_IN increased_VBN risk_NN of_IN
          impaired_VBN fasting_VBG lipid_NN profiles_NNS ,_, with_IN odds_NNS ratios_NNS of_IN 9_CD ._. 1_CD
          and_CC higher_JJR ._.
        
        
          Study_NNP 2_CD
          The_DT goal_NN of_IN the_DT second_JJ study_NN was_VBD to_TO determine_VB the_DT
          childhood_NN age_NN of_IN abnormal_JJ glucose_NN and_CC lipid_NN profiles_NNS from_IN
          overweight_NN adults_NNS ._. By_IN using_VBG a_DT retrospective-prospective_JJ
          longitudinal_NN study_NN design_NN we_PRP were_VBD able_JJ to_TO track_VB BMI_NNP ,_,
          glucose_NN and_CC lipid_NN profiles_NNS from_IN late_JJ childhood_NN and_CC
          adolescent_JJ ages_NNS to_TO adulthood_NN in_IN a_DT white_JJ Caucasian_NNP
          populations_NNS ._. Then_RB we_PRP were_VBD able_JJ to_TO correlate_VBP their_PRP$
          subsequent_JJ risk_NN of_IN obesity_NN and_CC its_PRP$ associated_VBN impaired_VBN
          glucose_NN and_CC lipid_NN profiles_NNS There_RB is_VBZ general_JJ agreement_NN on_IN
          the_DT use_NN of_IN BMI_NNP with_IN selected_VBN cutoff_NN points_NNS as_IN guidelines_NNS
          for_IN desirable_JJ weight_NN [_NN 44_CD 45_CD 46_CD 47_CD 48_CD ]_NN ._. This_DT study_NN
          provided_VBD a_DT basis_NN for_IN prediction_NN of_IN overweight_NN and_CC obesity_NN
          in_IN adults_NNS from_IN their_PRP$ 13_CD -_: 15_CD year_NN old_JJ group_NN ,_, suggesting_VBG
          that_IN this_DT simple_JJ measurement_NN could_MD be_VB applied_VBN to_TO the_DT
          prediction_NN of_IN obesity_NN in_IN public_JJ health_NN programs_NNS ._. The_DT
          results_NNS presented_VBN here_RB were_VBD comparable_JJ to_TO those_DT observed_VBD
          in_IN a_DT previous_JJ study_NN showing_VBG that_IN with_IN use_NN of_IN the_DT cutoff_NN
          point_NN of_IN the_DT 60_CD thpercentile_NN at_IN age_NN 18_CD y_NN ,_, the_DT odds_NNS ratios_NNS
          of_IN overweight_NN at_IN age_NN 35_CD y_NN were_VBD of_IN 15_CD for_IN males_NNS and_CC 27_CD for_IN
          females_NNS ,_, with_IN corresponding_JJ SEs_NNP of_IN 1_CD ._. 9_CD and_CC 3_CD ._. 5_CD
          respectively_RB ._. Previous_JJ data_NNS on_IN 8_CD -_: 18_CD y_NN olds_NNS in_IN Project_NNP
          Heart-_NNP Beat_NN demonstrated_VBN that_IN the_DT odds_NNS ratio_NN of_IN overweight_NN
          in_IN adulthood_NN for_IN those_DT with_IN childhood_NN BMI_NNP values_NNS at_IN the_DT
          95_CD thpercentile_NN were_VBD 2_CD -_: 6_CD and_CC 1_CD ._. 5_CD to_TO 5_CD times_NNS as_RB great_JJ as_IN
          for_IN those_DT with_IN a_DT BMI_NNP values_NNS at_IN the_DT 75_CD thpercentile_NN for_IN
          males_NNS and_CC females_NNS respectively_RB [_NN 49_CD ]_NN ._.
          The_DT incidence_NN of_IN impaired_VBN glucose_NN profile_NN was_VBD
          comparable_JJ between_IN boys_NNS and_CC girls_NNS ._. In_IN both_DT sexes_NNS the_DT
          incidence_NN of_IN diabetes_NN and_CC impaired_VBN fasting_VBG glucose_NN
          increased_VBD significantly_RB (_( 
          P_NN <_NN 0_CD ._. 001_CD )_) relative_JJ to_TO
          chronological_JJ age_NN in_IN comparison_NN to_TO adults_NNS ._. The_DT
          sensitivity_NN of_IN the_DT selected_VBN cutoff_NN point_NN for_IN BMI_NNP values_NNS
          at_IN the_DT 85_CD thpercentile_NN at_IN 13_CD -_: 15_CD years_NNS old_JJ for_IN identifying_VBG
          impaired_VBN glucose_NN profile_NN at_IN age_NN 35_CD y_NN was_VBD 76_CD ._. 4_LS %_NN and_CC 77_CD ._. 6_CD %_NN
          for_IN both_DT male_JJ and_CC female_JJ ,_, respectively_RB ._. Therefore_RB ,_, at_IN
          least_JJS 75_CD %_NN of_IN male_JJ and_CC female_JJ adolescents_NNS aged_VBN between_IN 13_CD
          and_CC 15_CD years_NNS old_JJ who_WP were_VBD having_VBG a_DT BMI_NNP ≥_NN 85_CD thwere_NN
          correctly_RB predicted_VBD to_TO have_VB impaired_VBN glucose_NN profile_NN at_IN
          35_CD y_NN ._. On_IN the_DT other_JJ hand_NN ,_, 77_CD ._. 8_CD %_NN of_IN male_JJ and_CC 71_CD ._. 4_LS %_NN of_IN
          female_JJ adolescents_NNS of_IN this_DT age_NN group_NN who_WP were_VBD having_VBG a_DT
          BMI_NNP ≤_NN 85_CD thwere_NN correctly_RB predicted_VBD to_TO have_VB normal_JJ
          glucose_NN profile_NN at_IN 35_CD y_NN ._. As_IN stated_VBN in_IN the_DT introduction_NN
          obesity_NN in_IN childhood_NN is_VBZ associated_VBN with_IN obesity_NN in_IN
          adulthood_NN [_NN 22_CD 23_CD 24_CD 25_CD ]_NN ,_, and_CC is_VBZ a_DT predictor_NN of_IN all_DT
          cause_NN of_IN obesity-associated_JJ mortality_NN during_IN adulthood_NN ,_,
          particularly_RB mortality_NN from_IN cardiovascular_JJ diseases_NNS ,_,
          which_WDT is_VBZ independent_JJ of_IN adult_NN weight_NN [_NN 24_CD 25_CD ]_NN ._. The_DT
          results_NNS of_IN the_DT present_JJ study_NN agreed_VBD with_IN a_DT previous_JJ study_NN
          [_NN 50_CD ]_NN indicating_VBG that_IN the_DT metabolic_JJ alterations_NNS caused_VBN
          by_IN excess_JJ body_NN fat_JJ are_VBP expressed_VBN early_RB in_IN the_DT natural_JJ
          history_NN of_IN obesity_NN ._. Such_JJ alterations_NNS seem_VBP clinically_RB
          important_JJ even_RB in_IN children_NNS ,_, as_IN evidenced_VBN by_IN an_DT increase_NN
          in_IN glucose_NN profile_NN abnormalities_NNS in_IN obese_NN adolescents_NNS ._.
          These_DT observations_NNS underscore_VBP the_DT need_NN for_IN research_NN
          efforts_NNS directed_VBN at_IN the_DT development_NN of_IN effective_JJ
          interventions_NNS for_IN obese_NN adolescents_NNS ._.
          The_DT incidence_NN of_IN impaired_VBN lipid_NN profile_NN was_VBD comparable_JJ
          between_IN boys_NNS and_CC girls_NNS ._. In_IN both_DT sexes_NNS the_DT incidence_NN of_IN
          impaired_VBN lipid_NN profile_NN increased_VBD significantly_RB (_( 
          P_NN <_NN 0_CD ._. 001_CD )_) relative_JJ to_TO
          chronological_JJ age_NN in_IN comparison_NN to_TO adults_NNS ._. The_DT
          sensitivity_NN of_IN the_DT selected_VBN cutoff_NN point_NN for_IN BMI_NNP values_NNS
          at_IN the_DT 85_CD thpercentile_NN at_IN 13_CD -_: 15_CD years_NNS old_JJ for_IN identifying_VBG
          impaired_VBN lipid_NN profile_NN at_IN age_NN 35_CD y_NN was_VBD 77_CD ._. 7_CD %_NN and_CC 79_CD ._. 2_LS %_NN
          for_IN both_DT male_JJ and_CC female_JJ ,_, respectively_RB ._. The_DT specificity_NN
          was_VBD 80_CD ._. 0_CD %_NN and_CC 75_CD ._. 0_CD %_NN ,_, for_IN both_DT male_JJ and_CC female_JJ ,_,
          respectively_RB ._. If_IN we_PRP consider_VBP that_IN most_JJS of_IN the_DT subjects_NNS
          having_VBG a_DT BMI_NNP ≥_NN 85_CD thwere_NN also_RB presenting_VBG more_JJR than_IN 2_CD risk_NN
          factors_NNS for_IN cardiovascular_JJ disease_NN ,_, this_DT means_VBZ that_IN they_PRP
          are_VBP at_IN increased_VBN risk_NN for_IN developing_VBG cardiovascular_JJ
          diseases_NNS ._. Few_JJ studies_NNS have_VBP examined_VBN the_DT long-term_JJ effects_NNS
          of_IN adolescent_JJ obesity_NN on_IN adult_NN disease_NN ._. Nonetheless_RB ,_,
          obesity_NN present_JJ in_IN childhood_NN or_CC adolescence_NN seems_VBZ to_TO
          increase_VB the_DT likelihood_NN of_IN adult_NN morbidity_NN and_CC mortality_NN
          [_NN 51_CD ]_NN ._. In_IN the_DT present_JJ study_NN we_PRP demonstrated_VBD that_IN in_IN
          both_DT men_NNS and_CC women_NNS obese_NN during_IN adolescence_NN ,_, risk_NN of_IN
          cardiovascular_JJ diseases_NNS and_CC diabetes_NN were_VBD increased_VBN ._.
          These_DT effects_NNS seems_VBZ related_VBN both_DT to_TO the_DT persistence_NN of_IN
          obesity_NN and_CC to_TO the_DT effects_NNS of_IN childhood_NN or_CC adolescent_JJ
          obesity_NN on_IN the_DT quantity_NN and_CC location_NN of_IN body_NN fat_JJ
          distribution_NN ._. The_DT risk_NN factors_NNS for_IN adult_NN disease_NN that_WDT are_VBP
          associated_VBN with_IN obesity_NN in_IN children_NNS and_CC adolescents_NNS
          persist_VBP into_IN adulthood_NN or_CC increase_NN in_IN prevalence_NN if_IN
          weight_NN gain_NN occurs_VBZ ._. Although_IN both_DT total_JJ body_NN fat_JJ and_CC
          regional_JJ fat_JJ deposition_NN could_MD account_VB for_IN the_DT association_NN
          of_IN childhood_NN or_CC adolescent_JJ obesity_NN with_IN adult_NN disease_NN ,_, no_DT
          studies_NNS to_TO date_NN have_VBP examined_VBN cardiovascular_JJ risk_NN factors_NNS
          and_CC related_VBD them_PRP to_TO visceral_NN fat_JJ ._.
        
      
      
        Conclusion_NNP
        The_DT strengths_NNS of_IN the_DT study_NN include_VBP the_DT use_NN of_IN large_JJ
        samples_NNS of_IN both_DT genders_NNS ,_, a_DT wide_JJ age_NN range_NN ,_, subjects_NNS
        representative_NN of_IN the_DT population_NN being_VBG studied_VBN ,_, precise_JJ
        measurements_NNS of_IN body_NN composition_NN and_CC the_DT use_NN of_IN
        well-accepted_JJ BMI_NNP classifications_NNS of_IN overweight_NN and_CC
        obesity_NN ._. By_IN using_VBG a_DT retrospective-prospective_JJ design_NN in_IN the_DT
        second_JJ part_NN of_IN the_DT study_NN we_PRP were_VBD able_JJ to_TO obtain_VB the_DT
        longitudinal_NN data_NN required_VBN to_TO answer_VB the_DT questions_NNS
        addressed_VBN ._. In_IN conclusion_NN our_PRP$ study_NN confirms_VBZ the_DT hypothesis_NNS
        that_WDT overweight_NN and_CC obese_NN adolescents_NNS have_VBP higher_JJR fasting_VBG
        plasma_NN glucose_NN and_CC insulin_NN levels_NNS ,_, and_CC an_DT abnormal_JJ lipid_NN
        profile_NN relative_JJ to_TO their_PRP$ lean_JJ peers_NNS ._. This_DT study_NN highlights_VBZ
        the_DT critical_JJ importance_NN of_IN early_JJ identification_NN and_CC
        intervention_NN of_IN adolescent_JJ obesity_NN to_TO avert_VB the_DT long-term_JJ
        consequences_NNS of_IN it_PRP and_CC to_TO protect_VB adolescent_JJ against_IN the_DT
        risk_NN of_IN cardiovascular_JJ diseases_NNS ._. There_EX is_VBZ an_DT urgent_JJ need_VBP to_TO
        follow_VB cohorts_NNS at-risks_JJ children_NNS and_CC adolescents_NNS to_TO
        investigate_VB cofactors_NNS acting_VBG in_IN concert_NN with_IN obesity_NN that_WDT
        are_VBP responsible_JJ for_IN the_DT early_JJ onset_NN of_IN risk_NN factors_NNS for_IN
        cardiovascular_JJ diseases_NNS ,_, a_DT phenomenon_NN increasingly_RB being_VBG
        observed_VBN in_IN many_JJ populations_NNS ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
    
  
